SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-050288
Filing Date
2017-08-08
Accepted
2017-08-08 16:40:52
Documents
55
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13357_110q.htm 10-Q 957072
2 EX-31.1 a17-13357_1ex31d1.htm EX-31.1 9719
3 EX-31.2 a17-13357_1ex31d2.htm EX-31.2 10195
4 EX-32 a17-13357_1ex32.htm EX-32 10962
  Complete submission text file 0001104659-17-050288.txt   4497154

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT inva-20170630.xml EX-101.INS 1021521
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20170630.xsd EX-101.SCH 40402
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20170630_cal.xml EX-101.CAL 52077
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20170630_def.xml EX-101.DEF 122561
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT inva-20170630_lab.xml EX-101.LAB 354446
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20170630_pre.xml EX-101.PRE 245251
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 171015368
SIC: 2834 Pharmaceutical Preparations